Catch up on the top radiology content of the past week.
|Articles|November 10, 2011
Kjaya Medical to Debut iShareScan.com
Kjaya Medical will introduce a cloud-based sharing solution at RSNA 2011 called iShareScan.com.
Advertisement
Kjaya Medical will introduce a cloud-based sharing solution at RSNA 2011 called iShareScan.com.
The solution, which the company is offering for free for imaging sites, makes images available for immediate access and manipulation in 2D, 3D, 4D or PET-CT fusion by authorized physicians and patients. It uses the same technology as their full per-study-fee-based VoXcell imaging suite.
Through iShareScan.com, imaging sites can grant image access for collaboration and communication with referring physicians, as well as allow patients to share their images with providers, the company said. Images are available on the cloud for up to 30 days without charge and can be stored for longer for a fee.
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Diagnostic Imaging's Weekly Scan: September 27 — October 3
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5